logo
Search orAI Icon𝛼SK
ENTITY
OBI Pharma Inc

OBI Pharma Inc (4174 TT)

6
Analysis
Health Care • Taiwan
OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.
more
Exchange Announcement • 05 Dec 2025 14:30

Obi Receives Us Fda Orphan Drug Designation For Obi-902 Trop2 Adc For The Treatment Of Gastric Cancer

Exchange Announcement • 24 Nov 2025 17:11

Announcement Of The Company’S Record Date Of Capital Reduction, Record Date Of Share Replacement, And Related Operational Plan

Exchange Announcement • 16 Nov 2025 14:17

Obi Receives Us Fda Orphan Drug Designation For Obi-902 Trop2 Adc For The Treatment Of Cholangiocarcinoma

Exchange Announcement • 14 Nov 2025 14:33

Obi Is Invited To Present The Current Development Status Of Its Products And Technology Platforms At The Investor Conference Hosted By Masterlink

Exchange Announcement • 10 Nov 2025 15:42

Announcement Of Bod’S Resolution To Lift The Non-Competition Restrictions For Managerial Officers

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x